Ratings Akzo Nobel India Limited NSE India S.E.

Equities

AKZOINDIA

INE133A01011

Market Closed - NSE India S.E. 07:43:47 2024-05-03 am EDT 5-day change 1st Jan Change
2,515 INR -0.33% Intraday chart for Akzo Nobel India Limited +2.88% -3.56%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Weaknesses

  • With a 2024 P/E ratio at 26.22 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Commodity Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-3.56% 1.38B -
-0.23% 77.23B
C+
-13.89% 34.2B
B-
-7.15% 16.16B
B
-2.11% 13.95B
B+
-15.90% 11.26B
B+
+3.33% 7.69B
B-
-13.48% 7.3B
B
-14.01% 2.83B
B-
-13.37% 2.76B
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality